Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Jerini> ?p ?o }
Showing triples 1 to 83 of
83
with 100 triples per page.
- Jerini abstract "Jerini AG was a pharmaceutical company based in Berlin, Germany, which focused on the discovery and development of novel peptide-based drugs. Using a proprietary technology platform, Peptides-to-Drugs (P2D), Jerini pursued disease indications for which limited, inadequate, or no treatment options exist. As a result, Jerini established a drug pipeline composed of its own programs as well as others in collaboration with partners. Jerini's commercialization strategy was to market new drugs in niche indications independently and in larger indications with partners. Jerini was acquired by Shire plc in 2008.Jerini started operations in 1994. Jerini's subsidiaries Jerini US Inc. and JPT Peptide Technologies GmbH, provider of peptides and peptide microarrays, were acquired by Theracode GmbH, Mainz in 2009. Jerini was financed with venture capital provided by TVM and HealthCap. It went public on the Prime Standard of the Frankfurt Stock Exchange (JI4), and had raised a total of over 130 million Euro in public and private financing to date.".
- Jerini foundationPlace Berlin.
- Jerini foundationPlace Germany.
- Jerini foundingYear "1994".
- Jerini location Berlin.
- Jerini location Germany.
- Jerini numberOfEmployees "139".
- Jerini product Icatibant.
- Jerini thumbnail Jerini_285_93.jpg?width=300.
- Jerini wikiPageExternalLink www.hae-network.info.
- Jerini wikiPageExternalLink www.jerini.com.
- Jerini wikiPageExternalLink www.jpt.com.
- Jerini wikiPageID "6588551".
- Jerini wikiPageLength "4724".
- Jerini wikiPageOutDegree "25".
- Jerini wikiPageRevisionID "679835292".
- Jerini wikiPageWikiLink Angioedema.
- Jerini wikiPageWikiLink Berlin.
- Jerini wikiPageWikiLink Bradykinin.
- Jerini wikiPageWikiLink Bradykinin_receptor_B2.
- Jerini wikiPageWikiLink Category:Companies_based_in_Berlin.
- Jerini wikiPageWikiLink Category:Pharmaceutical_companies_established_in_1994.
- Jerini wikiPageWikiLink Category:Pharmaceutical_companies_of_Germany.
- Jerini wikiPageWikiLink Food_and_Drug_Administration.
- Jerini wikiPageWikiLink Germany.
- Jerini wikiPageWikiLink HealthCap.
- Jerini wikiPageWikiLink Icatibant.
- Jerini wikiPageWikiLink Inflammation.
- Jerini wikiPageWikiLink Macular_degeneration.
- Jerini wikiPageWikiLink Oncology.
- Jerini wikiPageWikiLink Ophthalmology.
- Jerini wikiPageWikiLink Peptide.
- Jerini wikiPageWikiLink Peptide_microarray.
- Jerini wikiPageWikiLink Pharmaceutical_industry.
- Jerini wikiPageWikiLink Sanofi.
- Jerini wikiPageWikiLink Shire_(pharmaceutical_company).
- Jerini wikiPageWikiLink Venture_capital.
- Jerini wikiPageWikiLink File:Jerini_285_93.jpg.
- Jerini wikiPageWikiLinkText "Jerini".
- Jerini foundation Berlin.
- Jerini foundation Germany.
- Jerini homepage www.jerini.com.
- Jerini keyPeople "Adi Hoess, Chief Commercial Officer".
- Jerini keyPeople "Berndt Modig, Chief Financial Officer".
- Jerini keyPeople "Jens Schneider-Mergener, CEO".
- Jerini keyPeople "Jochen Knolle, Chief Scientific Officer, Head of R & D".
- Jerini location "Berlin, Germany".
- Jerini logo File:Jerini_285_93.jpg.
- Jerini name "Jerini AG".
- Jerini numEmployees "139".
- Jerini products Icatibant.
- Jerini wikiPageUsesTemplate Template:Citation_needed.
- Jerini wikiPageUsesTemplate Template:Infobox_company.
- Jerini wikiPageUsesTemplate Template:Reflist.
- Jerini subject Category:Companies_based_in_Berlin.
- Jerini subject Category:Pharmaceutical_companies_established_in_1994.
- Jerini subject Category:Pharmaceutical_companies_of_Germany.
- Jerini hypernym Company.
- Jerini type Agent.
- Jerini type Company.
- Jerini type Drug.
- Jerini type Organisation.
- Jerini type Company.
- Jerini type Drug.
- Jerini type Organisation.
- Jerini type Organization.
- Jerini type Agent.
- Jerini type SocialPerson.
- Jerini type Thing.
- Jerini type Q43229.
- Jerini comment "Jerini AG was a pharmaceutical company based in Berlin, Germany, which focused on the discovery and development of novel peptide-based drugs. Using a proprietary technology platform, Peptides-to-Drugs (P2D), Jerini pursued disease indications for which limited, inadequate, or no treatment options exist. As a result, Jerini established a drug pipeline composed of its own programs as well as others in collaboration with partners.".
- Jerini label "Jerini".
- Jerini sameAs Q319924.
- Jerini sameAs Jerini.
- Jerini sameAs Jerini.
- Jerini sameAs Jerini.
- Jerini sameAs m.0gctck.
- Jerini sameAs Q319924.
- Jerini wasDerivedFrom Jerini?oldid=679835292.
- Jerini depiction Jerini_285_93.jpg.
- Jerini homepage www.jerini.com.
- Jerini isPrimaryTopicOf Jerini.
- Jerini name "Jerini AG".